Zobrazeno 1 - 10
of 396
pro vyhledávání: '"P, Schmoor"'
The SAVVY project aims to improve the analyses of adverse events (AEs) in clinical trials through the use of survival techniques appropriately dealing with varying follow-up times and competing events (CEs). This paper summarizes key features and con
Externí odkaz:
http://arxiv.org/abs/2402.17692
The adoption of data science brings vast benefits to Small and Medium-sized Enterprises (SMEs) including business productivity, economic growth, innovation and jobs creation. Data Science can support SMEs to optimise production processes, anticipate
Externí odkaz:
http://arxiv.org/abs/2305.15454
Autor:
Johanna Thomas, Usama-Ur Rehman, Helena Bresser, Olga Grishina, Dietmar Pfeifer, Etienne Sollier, Konstanze Döhner, Christoph Plass, Heiko Becker, Claudia Schmoor, Maike de Wit, Michael Lübbert
Publikováno v:
Clinical Epigenetics, Vol 16, Iss 1, Pp 1-5 (2024)
Abstract DNA-hypomethylating agents (HMAs) induce notable remission rates in AML/MDS patients with TP53 mutations; however, secondary resistance often develops rapidly. In the DECIDER trial (NCT00867672), elderly AML patients (also those with adverse
Externí odkaz:
https://doaj.org/article/1be44a233b44476594d325965bb4fbac
Autor:
Dimitra Kiritsi, Franziska Schauer, Stella Gewert, Katja Reineker, Antonia Reimer-Taschenbrecker, Agnes Schwieger-Briel, Hagen Ott, Claudia Schmoor, Olga Grishina, Dedee Murrell, Brigitte Stiller, Tobias Zahn, Alexander Nyström, Leena Bruckner-Tuderman
Publikováno v:
EClinicalMedicine, Vol 77, Iss , Pp 102900- (2024)
Summary: Background: Recessive dystrophic epidermolysis bullosa (RDEB) is a skin fragility disorder characterised by life-long mechanically induced skin blistering, fibrosis-driven pseudosyndactyly, and multi-organ involvement. Preclinical studies ha
Externí odkaz:
https://doaj.org/article/ceaea83a01bb41de80f3d86b05684855
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background The SAVVY project aims to improve the analyses of adverse events (AEs) in clinical trials through the use of survival techniques appropriately dealing with varying follow-up times and competing events (CEs). This paper summarizes
Externí odkaz:
https://doaj.org/article/bafe00c99c664a52b3b7b6c209ee7464
Autor:
Sven Ziegler, Claudia Schmoor, Lili M. Schöler, Sam Schepputat, Eyere Takem, Birgit Grotejohann, Inga Steinbrenner, Johanna Feuchtinger
Publikováno v:
BMC Nursing, Vol 22, Iss 1, Pp 1-10 (2023)
Abstract Background Pressure ulcer prophylaxis is a central topic in clinical care. Pressure-relieving repositioning is strongly recommended for all pressure-sensitive patients. The Mobility Monitor (MoMo) is a technical device that records a patient
Externí odkaz:
https://doaj.org/article/c95bb77866d048e6b04d6f9db0068392
Autor:
Abiodun Ayantayo, Amrit Kaur, Anit Kour, Xavier Schmoor, Fayyaz Shah, Ian Vickers, Paul Kearney, Mohammed M. Abdelsamea
Publikováno v:
Journal of Big Data, Vol 10, Iss 1, Pp 1-24 (2023)
Abstract Network intrusion detection systems (NIDSs) are one of the main tools used to defend against cyber-attacks. Deep learning has shown remarkable success in network intrusion detection. However, the effect of feature fusion has yet to be explor
Externí odkaz:
https://doaj.org/article/3ca750394d1441588382cec3c837e6e5
Autor:
Nora Rebeka Javorniczky, Olga Grishina, Inga Hund, Milena Pantic, Dietmar Pfeifer, Claudia Schmoor, Johanna Thomas, Justus Duyster, Heiko Becker, Michael Lübbert
Publikováno v:
Clinical Epigenetics, Vol 15, Iss 1, Pp 1-5 (2023)
Abstract Elderly patients with AML ineligible for induction have a dismal prognosis; hence disease stabilization is a primary treatment goal. This case of a 75-year-old patient with secondary AML receiving the combination of decitabine and ATRA (with
Externí odkaz:
https://doaj.org/article/6085df4c75ec4101b2942e2480228aaa
As a reaction to the pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a multitude of clinical trials for the treatment of SARS-CoV-2 or the resulting corona disease (COVID-19) are globally at various stages from planning
Externí odkaz:
http://arxiv.org/abs/2012.02103
Autor:
Rufibach, Kaspar, Stegherr, Regina, Schmoor, Claudia, Jehl, Valentine, Allignol, Arthur, Boeckenhoff, Annette, Dunger-Baldauf, Cornelia, Eisele, Lewin, Künzel, Thomas, Kupas, Katrin, Leverkus, Friedhelm, Trampisch, Matthias, Zhao, Yumin, Friede, Tim, Beyersmann, Jan
Analyses of adverse events (AEs) are an important aspect of the evaluation of experimental therapies. The SAVVY (Survival analysis for AdVerse events with Varying follow-up times) project aims to improve the analyses of AE data in clinical trials thr
Externí odkaz:
http://arxiv.org/abs/2008.07881